These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1386 related items for PubMed ID: 28558837

  • 1. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF, Miravitlles M.
    Respir Res; 2017 May 30; 18(1):105. PubMed ID: 28558837
    [Abstract] [Full Text] [Related]

  • 2. Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.
    Tortorici MA, Rogers JA, Vit O, Bexon M, Sandhaus RA, Burdon J, Chorostowska-Wynimko J, Thompson P, Stocks J, McElvaney NG, Chapman KR, Edelman JM.
    Br J Clin Pharmacol; 2017 Nov 30; 83(11):2386-2397. PubMed ID: 28662542
    [Abstract] [Full Text] [Related]

  • 3. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG, Patel M, Bayliss S, Crossley D, Sapey E, Turner AM.
    Int J Chron Obstruct Pulmon Dis; 2017 Nov 30; 12():1295-1308. PubMed ID: 28496314
    [Abstract] [Full Text] [Related]

  • 4. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F, Blanco I, Martínez MT, Bustamante A, Miravitlles M, Cadenas S, Hernández JM, Lázaro L, Rodríguez E, Rodríguez-Frías F, Torres M, Lara B.
    Arch Bronconeumol; 2015 Apr 30; 51(4):185-92. PubMed ID: 25027067
    [Abstract] [Full Text] [Related]

  • 5. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S, Camprubi S, Griffin R, Chen J, Ayguasanosa J.
    Respir Med; 2015 Apr 30; 109(4):490-9. PubMed ID: 25727857
    [Abstract] [Full Text] [Related]

  • 6. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
    Chapman KR, Chorostowska-Wynimko J, Koczulla AR, Ferrarotti I, McElvaney NG.
    Int J Chron Obstruct Pulmon Dis; 2018 Apr 30; 13():419-432. PubMed ID: 29430176
    [Abstract] [Full Text] [Related]

  • 7. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN, McCarthy C, McElvaney NG.
    Expert Rev Respir Med; 2015 Apr 30; 9(2):143-51. PubMed ID: 25598013
    [Abstract] [Full Text] [Related]

  • 8. Disease Modification in Emphysema Related to Alpha-1 Antitrypsin Deficiency.
    Chorostowska-Wynimko J.
    COPD; 2016 Dec 30; 13(6):807-815. PubMed ID: 27172295
    [Abstract] [Full Text] [Related]

  • 9. Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.
    Parr DG, Lara B.
    Drug Des Devel Ther; 2017 Dec 30; 11():2149-2162. PubMed ID: 28769553
    [Abstract] [Full Text] [Related]

  • 10. Small airways disease in patients with alpha-1 antitrypsin deficiency.
    Toumpanakis D, Usmani OS.
    Respir Med; 2023 May 30; 211():107222. PubMed ID: 36965591
    [Abstract] [Full Text] [Related]

  • 11. Alpha-1 antitrypsin (AAT) augmentation therapy in individuals with the PI*MZ genotype: a pro/con debate on a working hypothesis.
    Barjaktarevic I, Miravitlles M.
    BMC Pulm Med; 2021 Mar 23; 21(1):99. PubMed ID: 33757485
    [Abstract] [Full Text] [Related]

  • 12. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR, Burdon JG, Piitulainen E, Sandhaus RA, Seersholm N, Stocks JM, Stoel BC, Huang L, Yao Z, Edelman JM, McElvaney NG, RAPID Trial Study Group.
    Lancet; 2015 Jul 25; 386(9991):360-8. PubMed ID: 26026936
    [Abstract] [Full Text] [Related]

  • 13. Augmentation Therapy for Severe Alpha-1 Antitrypsin Deficiency Improves Survival and Is Decoupled from Spirometric Decline-A Multinational Registry Analysis.
    Fraughen DD, Ghosh AJ, Hobbs BD, Funk GC, Meischl T, Clarenbach CF, Sievi NA, Schmid-Scherzer K, McElvaney OJ, Murphy MP, Roche AD, Clarke L, Strand M, Vafai-Tabrizi F, Kelly G, Gunaratnam C, Carroll TP, McElvaney NG.
    Am J Respir Crit Care Med; 2023 Nov 01; 208(9):964-974. PubMed ID: 37624745
    [Abstract] [Full Text] [Related]

  • 14. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA, Lascano J.
    Ther Adv Respir Dis; 2014 Oct 01; 8(5):150-61. PubMed ID: 25013223
    [Abstract] [Full Text] [Related]

  • 15. Randomized, Placebo-Controlled Trials in Alpha-1 Antitrypsin Deficiency.
    Sandhaus RA.
    Ann Am Thorac Soc; 2016 Aug 01; 13 Suppl 4():S370-3. PubMed ID: 27564674
    [Abstract] [Full Text] [Related]

  • 16. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD, Crystal RG.
    COPD; 2013 Mar 01; 10 Suppl 1():64-7. PubMed ID: 23527997
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
    Dummer J, Dobler CC, Holmes M, Chambers D, Yang IA, Parkin L, Smith S, Wark P, Dev A, Hodge S, Dabscheck E, Gooi J, Samuel S, Knowles S, Holland AE.
    Respirology; 2020 Mar 01; 25(3):321-335. PubMed ID: 32030868
    [Abstract] [Full Text] [Related]

  • 18. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S, Turato G, Lunardi F, Bazzan E, Schiavon M, Ferrarotti I, Molena B, Cazzuffi R, Damin M, Balestro E, Luisetti M, Rea F, Calabrese F, Cosio MG, Saetta M.
    Am J Respir Crit Care Med; 2015 Feb 15; 191(4):402-9. PubMed ID: 25412116
    [Abstract] [Full Text] [Related]

  • 19.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Stoller JK, Hupertz V, Aboussouan LS.
    ; 1993 Feb 15. PubMed ID: 20301692
    [Abstract] [Full Text] [Related]

  • 20. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT, Ford GT, Chapman KR.
    Treat Respir Med; 2005 Feb 15; 4(1):1-8. PubMed ID: 15725045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 70.